Pinealon is a synthetic tripeptide — glutamic acid-aspartic acid-arginine (EDR) — developed from research into pineal gland-derived bioregulators. It belongs to the same family of geroprotective peptides as Epithalon and Cortagen, developed by the St. Petersburg Institute of Bioregulation and Gerontology. Pinealon is primarily researched for its neuroprotective, cognitive, and sleep-regulating properties.
What is Pinealon?
Pinealon is a tripeptide bioregulator designed to interact with the central nervous system, particularly neuronal cells. Unlike neurotransmitter-based nootropics that act on receptor systems, Pinealon operates at the gene expression level — it crosses into cells and modulates the transcription of genes related to neuronal survival, mitochondrial function, and circadian rhythm regulation. This epigenetic mechanism distinguishes it from most conventional cognitive research compounds.
The peptide was developed as part of a broader programme to identify short peptide bioregulators that could restore age-related functional decline in specific organs and tissues. The pineal gland produces melatonin and orchestrates circadian biology — hence Pinealon's particular relevance to sleep quality and chronobiology research.
Neuroprotection Research
Pinealon's most studied application is neuroprotection. In animal models of hypoxia, ischaemia, and oxidative stress, Pinealon administration reduced neuronal apoptosis and improved post-injury functional outcomes. The proposed mechanism involves upregulation of anti-apoptotic proteins (Bcl-2 family) and downregulation of pro-apoptotic caspase activity within neuronal tissue.
Research has also shown Pinealon to support mitochondrial membrane integrity in cortical neurons under oxidative challenge, suggesting a role in preserving the energy substrate for cognitive function. This mitochondrial neuroprotective angle has drawn interest from researchers studying age-related cognitive decline.
Cognitive Enhancement
Studies in aged rodents have demonstrated that Pinealon improves spatial memory, learning speed, and cognitive flexibility — metrics that typically decline with age-related neurodegeneration. The improvements appear correlated with increased BDNF (brain-derived neurotrophic factor) expression and enhanced synaptic plasticity markers in the hippocampus. For researchers exploring nootropic peptides, Pinealon stacks naturally with Semax, which also upregulates BDNF through a complementary pathway involving the ACTH fragment sequence.
Unlike stimulant-based cognitive enhancers, Pinealon does not produce tolerance or acute excitatory effects — its benefits appear to accumulate over repeated administration, consistent with its gene-regulatory mechanism.
Sleep Quality and Circadian Research
Given its pineal gland origin, Pinealon has been studied for effects on melatonin synthesis and circadian rhythm regulation. Research suggests it may support the restoration of melatonin production in aged subjects where pineal calcification has reduced endogenous output. This positions Pinealon as a potential research tool for sleep architecture studies, particularly in aged models where slow-wave sleep deterioration is prominent.
Evening administration timing is commonly used in protocols targeting circadian biology, reflecting the natural nocturnal activity of the pineal gland.
Research Dosage Protocol
Standard research dosage: 5–10 mg per day
Administration: Subcutaneous injection after reconstitution with bacteriostatic water. Use the BAC water reconstitution calculator to determine your working concentration. Courses of 10–14 days are commonly used in research protocols, with repeat courses after a rest period.
Storage: Lyophilised powder at -20°C; reconstituted solution at 4°C, use within 4 weeks.
Where to Buy Pinealon in India
Peptide Central stocks Pinealon at 99% purity, independently HPLC-verified with a full Certificate of Analysis included. Pan-India delivery with COD available. Researchers focused on cognitive peptides may also be interested in Semax, which pairs synergistically with Pinealon for combined BDNF upregulation and neuroprotective research. Both are available in our brain peptides collection.